|
Volumn 54, Issue 8, 2000, Pages 1710-
|
Ibuprofen treatment versus gradual introduction of interferon β-1b in patients with MS [3]
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IBUPROFEN;
INTERFERON BETA SERINE;
INTERLEUKIN 6;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PREDNISONE;
STEROID;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DOSE RESPONSE;
DRUG TOLERABILITY;
FEVER;
FLU LIKE SYNDROME;
HUMAN;
LETTER;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MONONUCLEAR CELL;
MULTIPLE SCLEROSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
|
EID: 18244424224
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/WNL.54.8.1710 Document Type: Letter |
Times cited : (7)
|
References (3)
|